Physician profile
Rahul Jain
NPI 1003018201
$10,338.73
in general payments reported to CMS, 2019-2025
17 companies · $2,794 in 2025
The $2,794 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $166 · 2022: $2,123 · 2023: $2,261 · 2024: $2,996 · 2025: $2,794.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,101 · Food and Beverage: $3,950.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,100.59 |
| Food and Beverage | $3,949.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $4,628.38 | 2021-2025 | Evera Mri Xt Dr Surescan, Cobalt Dr Mri Surescan, Micra |
| Atricure, INC. | $1,702.92 | 2025 | Epi-Sense Guided Coagulation System With Visitrax, Synergy Ablation System |
| Janssen Research & Development, LLC | $1,248.20 | 2023 | |
| Biosense Webster, INC. | $1,065.61 | 2023-2025 | Octaray Mapping Catheter, Carto 3, Qdot Micro |
| Impulse Dynamics (USA) INC. | $659.17 | 2022 | |
| Abbott Laboratories | $588.86 | 2021-2025 | Aveir, Ensite Precision, Mitraclip |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $77.84 | 2022-2025 | Lifevest |
| Becton, Dickinson and Company | $59.43 | 2024-2025 | |
| Cardiva Medical, INC. | $49.76 | 2023-2024 | Cardiva Vascade Mvp Vvcs 6-12f |
| Siemens Medical Solutions USA, INC. | $46.16 | 2023-2025 | Truebeam |
| Janssen Scientific Affairs, LLC | $45.04 | 2022 | |
| Amgen INC. | $42.49 | 2022-2024 | Repatha |
| Pfizer INC. | $31.13 | 2022-2023 | |
| Edwards Lifesciences Corporation | $27.61 | 2023 | Pascal |
| Altathera Pharmaceuticals LLC | $24.50 | 2024 | Sotalol Hydrochloride |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cordis US Corp. | $23.13 | 2025 | Mynx Control Venous |
| Chiesi USA, INC. | $18.50 | 2025 | Cleviprex, Kengreal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rahul Jain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.